Stonebridge Capital Management Inc Acadia Pharmaceuticals Inc Transaction History

Stonebridge Capital Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 02, 2019	SELL	$22.22 - $44.01 $198,869 - $393,889	-8,950 Closed	0 $0
Q2 2019 Jul 12, 2019	BUY	$23.32 - $28.12 $8,162 - $9,842	350 Added 4.07%	8,950 $239,000
Q1 2019 May 02, 2019	SELL	$16.17 - $27.38 $90,632 - $153,464	-5,605 Reduced 39.46%	8,600 $231,000
Q4 2018 Jan 25, 2019	BUY	$14.32 - $22.92 $25,418 - $40,683	1,775 Added 14.28%	14,205 $230,000
Q3 2018 Oct 17, 2018	SELL	$13.03 - $21.81 $5,212 - $8,724	-400 Reduced 3.12%	12,430 $258,000
Q2 2018 Jul 06, 2018	BUY	$15.07 - $22.34 $193,348 - $286,622	12,830 New	12,830 $213,000

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.65B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Stonebridge Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Stonebridge Capital Management Inc with notifications on news.